ADAM23 Gene Variants May Contribute to Focal Epilepsy
This study looked at a specific gene called ADAM23 and its potential role in causing focal epilepsy, which is a type of seizure disorder.
-
-
Devices & Neuromodulation | Epilepsy Research Summaries | Genetics | Imaging & EEG | Pediatrics | Recent Research
Surgery May Help Some Kids with SYNGAP1 Epilepsy
This study looked at children with a specific genetic condition called SYNGAP1-related developmental and epileptic encephalopathy (DEE), which causes severe developmental issues and epilepsy.
-
ePVS Density May Not Indicate Epileptogenicity in Patients
Researchers studied the connection between enlarged perivascular spaces (ePVS) in the brain and certain markers of epilepsy in patients undergoing a specific type of brain monitoring called stereo-electroencephalography (SEEG).
-
Understanding the Varied Effects of 15q11.2 Genetic Changes
This study looked at 37 children who had changes in a specific part of their DNA called the 15q11.2 region.
-
New Genetic Variant Found in Rare Ataxia Disorder
This study looked at a rare genetic disorder called spinocerebellar ataxia type 13 (SCAR13) in two families from Pakistan.
-
Unreported Lab Data Hinders Care for Pediatric Epilepsy Patients
Researchers studied how often unreported information about genetic changes, known as variants of uncertain significance (VUS), is found in children with epilepsy.
-
Gamma Stimulation May Boost Cognitive Function in Alzheimer’s Patients
Researchers studied the effects of gamma rhythm stimulation, specifically at 40 Hz, on cognitive function in people with Alzheimer’s disease (AD).
-
Epilepsy Research Summaries | Genetics | Imaging & EEG | Ketogenic Diet | Pediatrics | Recent Research
BCKDK Gene Mutations Linked to Autism and Developmental Delays
This study looked at four children who had mutations in a specific gene called BCKDK.
-
New Biomarkers Found for Drug-Resistant Epilepsy Using Imaging
Researchers conducted a systematic review to explore how advanced imaging techniques can identify neuro-inflammatory biomarkers in people with epilepsy who do not respond to medication.
